BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21382456)

  • 41. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.
    Burger-van Paassen N; Vincent A; Puiman PJ; van der Sluis M; Bouma J; Boehm G; van Goudoever JB; van Seuningen I; Renes IB
    Biochem J; 2009 May; 420(2):211-9. PubMed ID: 19228118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.
    Joshi AA; Wu Z; Reed RF; Suttle DP
    Mol Pharmacol; 2003 Feb; 63(2):359-67. PubMed ID: 12527807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered expression of topoisomerase IIalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation.
    Asano T; Nakamura K; Fujii H; Horichi N; Ohmori T; Hasegawa K; Isoe T; Adachi M; Otake N; Fukunaga Y
    Br J Cancer; 2005 Apr; 92(8):1486-92. PubMed ID: 15798770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.
    Hengstler JG; Lange J; Kett A; Dornhöfer N; Meinert R; Arand M; Knapstein PG; Becker R; Oesch F; Tanner B
    Cancer Res; 1999 Jul; 59(13):3206-14. PubMed ID: 10397267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study.
    Fritz P; Cabrera CM; Dippon J; Gerteis A; Simon W; Aulitzky WE; van der Kuip H
    Breast Cancer Res; 2005; 7(3):R374-84. PubMed ID: 15987433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene regulation and priming by topoisomerase IIα in embryonic stem cells.
    Thakurela S; Garding A; Jung J; Schübeler D; Burger L; Tiwari VK
    Nat Commun; 2013; 4():2478. PubMed ID: 24072229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topoisomerase IIalpha expression in ductal carcinoma in situ of the breast: a preliminary study.
    Shpitz B; Bomstein Y; Zehavi T; Bernheim J; Liverant S; Kaufman Z; Buklan G; Klein E
    Hum Pathol; 2000 Oct; 31(10):1249-54. PubMed ID: 11070118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
    Harris LN; Yang L; Tang C; Yang D; Lupu R
    Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer.
    Arpino G; Ciocca DR; Weiss H; Allred DC; Daguerre P; Vargas-Roig L; Leuzzi M; Gago F; Elledge R; Mohsin SK
    Breast Cancer Res Treat; 2005 Jul; 92(1):69-75. PubMed ID: 15980993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topoisomerase IIα levels and G2 radiosensitivity in T-lymphocytes of women presenting with breast cancer.
    Bryant PE; Riches AC; Shovman O; Dewar JA; Adamson DJ
    Mutagenesis; 2012 Nov; 27(6):737-41. PubMed ID: 22935224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does polysomy of chromosome 17 have a role in ERBB2 and topoisomerase IIalpha expression? Gene, mRNA and protein expression: a comprehensive analysis.
    Corzo C; Bellosillo B; Corominas JM; Salido M; Coll MD; Serrano S; Albanell J; Solé F; Tusquets I
    Tumour Biol; 2007; 28(4):221-8. PubMed ID: 17717428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA topoisomerase IIalpha protein and mRNA expression in intracranial meningiomas.
    Kunishio K; Morisaki K; Matsumoto Y; Nagao S
    Brain Tumor Pathol; 2000; 17(3):105-10. PubMed ID: 11310917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity.
    Uesaka T; Shono T; Kuga D; Suzuki SO; Niiro H; Miyamoto K; Matsumoto K; Mizoguchi M; Ohta M; Iwaki T; Sasaki T
    J Neurooncol; 2007 Sep; 84(2):119-29. PubMed ID: 17361331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the 3' untranslated region of mouse DNA topoisomerase IIalpha mRNA.
    Kobayashi M; Adachi N; Koyama H
    Gene; 1998 Jul; 215(2):329-37. PubMed ID: 9714832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA damage, DNA repair gene expression, and topoisomerase IIα activity in CD-1 mice following in utero benzene exposure.
    Holmes TH; Winn LM
    Toxicol Lett; 2022 Sep; 368():47-55. PubMed ID: 35963423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of DNA topoisomerase I, IIalpha, and IIbeta in human brain tumors.
    Morisaki K; Kuroda S; Matsumoto Y; Kunishio K; Nagao S
    Brain Tumor Pathol; 2000; 17(1):7-13. PubMed ID: 10982004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival.
    Zhao H; Yu H; Liu Y; Wang Y; Cai W
    Clin Neuropathol; 2008; 27(2):83-90. PubMed ID: 18402387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. c-Myb trans-activates the human DNA topoisomerase IIalpha gene promoter.
    Brandt TL; Fraser DJ; Leal S; Halandras PM; Kroll AR; Kroll DJ
    J Biol Chem; 1997 Mar; 272(10):6278-84. PubMed ID: 9045645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.
    Coustry F; Hu Q; de Crombrugghe B; Maity SN
    J Biol Chem; 2001 Nov; 276(44):40621-30. PubMed ID: 11514576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.